Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/159059 |
Resumo: | Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorly soluble in water. The objective of present research work was to prepare fast dissolving tablets of Flurbiprofen using varying concentrations of three different sublimating agents to improve the dissolution rate. Seven formulations were prepared containing different concentrations of camphor, ammonium bicarbonate and thymol as sublimating agent along with primogel as a superdisintegrant. Tablets were manufactured by direct compression method. The prepared tablets were evaluated for pre-compression and post-compression parameters result, For all formulations result was within official limits. FTIR studies revealed that there were no interactions between the drug and the excipients used. From in vitro drug release studies it was concluded that the formulations F6 and F7 containing 10% and 15% of thymol showed fast drug release of 100.00% and 100.84% respectively in 30 minutes. Formulations containing camphor (F2 & F3) and ammonium bicarbonate (F4 & F5) as sublimating agents showed a drug release of less than 80%, while the control formulation F1 having no sublimating agent showed 49.14% of drug release in 30 minutes. Thus thymol can successfully be used to formulate fast dissolving tablets of flurbiprofen by sublimation method with much better dissolution profile. |
id |
USP-31_be380e742691d6e7f2ec1ff80e06b8f6 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/159059 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluationFlurbiprofen/dissolutionFast dissolving tabletsDrug releaseSublimating agentSuperdisintegrantFlurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorly soluble in water. The objective of present research work was to prepare fast dissolving tablets of Flurbiprofen using varying concentrations of three different sublimating agents to improve the dissolution rate. Seven formulations were prepared containing different concentrations of camphor, ammonium bicarbonate and thymol as sublimating agent along with primogel as a superdisintegrant. Tablets were manufactured by direct compression method. The prepared tablets were evaluated for pre-compression and post-compression parameters result, For all formulations result was within official limits. FTIR studies revealed that there were no interactions between the drug and the excipients used. From in vitro drug release studies it was concluded that the formulations F6 and F7 containing 10% and 15% of thymol showed fast drug release of 100.00% and 100.84% respectively in 30 minutes. Formulations containing camphor (F2 & F3) and ammonium bicarbonate (F4 & F5) as sublimating agents showed a drug release of less than 80%, while the control formulation F1 having no sublimating agent showed 49.14% of drug release in 30 minutes. Thus thymol can successfully be used to formulate fast dissolving tablets of flurbiprofen by sublimation method with much better dissolution profile.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15905910.1590/s2175-97902018000417061Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17061Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17061Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e170612175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/159059/153987Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccessShaheen, NabeelaZaman, Shahiq uz2019-06-24T20:15:38Zoai:revistas.usp.br:article/159059Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-06-24T20:15:38Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
title |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
spellingShingle |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation Shaheen, Nabeela Flurbiprofen/dissolution Fast dissolving tablets Drug release Sublimating agent Superdisintegrant |
title_short |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
title_full |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
title_fullStr |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
title_full_unstemmed |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
title_sort |
Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation |
author |
Shaheen, Nabeela |
author_facet |
Shaheen, Nabeela Zaman, Shahiq uz |
author_role |
author |
author2 |
Zaman, Shahiq uz |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Shaheen, Nabeela Zaman, Shahiq uz |
dc.subject.por.fl_str_mv |
Flurbiprofen/dissolution Fast dissolving tablets Drug release Sublimating agent Superdisintegrant |
topic |
Flurbiprofen/dissolution Fast dissolving tablets Drug release Sublimating agent Superdisintegrant |
description |
Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorly soluble in water. The objective of present research work was to prepare fast dissolving tablets of Flurbiprofen using varying concentrations of three different sublimating agents to improve the dissolution rate. Seven formulations were prepared containing different concentrations of camphor, ammonium bicarbonate and thymol as sublimating agent along with primogel as a superdisintegrant. Tablets were manufactured by direct compression method. The prepared tablets were evaluated for pre-compression and post-compression parameters result, For all formulations result was within official limits. FTIR studies revealed that there were no interactions between the drug and the excipients used. From in vitro drug release studies it was concluded that the formulations F6 and F7 containing 10% and 15% of thymol showed fast drug release of 100.00% and 100.84% respectively in 30 minutes. Formulations containing camphor (F2 & F3) and ammonium bicarbonate (F4 & F5) as sublimating agents showed a drug release of less than 80%, while the control formulation F1 having no sublimating agent showed 49.14% of drug release in 30 minutes. Thus thymol can successfully be used to formulate fast dissolving tablets of flurbiprofen by sublimation method with much better dissolution profile. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-12-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/159059 10.1590/s2175-97902018000417061 |
url |
https://www.revistas.usp.br/bjps/article/view/159059 |
identifier_str_mv |
10.1590/s2175-97902018000417061 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/159059/153987 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17061 Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17061 Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17061 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222913854439424 |